Genetic regulation of host defense mechanisms by mucosal...

Details Genetic regulation of host defense mechanisms by mucosal... Genetic regulation of host defense mechanisms by mucosal...

A - Human Necessities

61

K

A61K 38/21 (2006.01) A61K 31/19 (2006.01) A61P 31/04 (2006.01) A61P 33/02 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2715294

A mixture of .alpha.-interferons (IFN-.alpha.) is used in vitro or in vivo as an antimicrobial agent or anticancer agent. It may be administered by topical application to oral or nasal, and/or buccal mucosa to combat the effects of infection by bacteria or protozoa, cancer, or other pathogenic disease process (e.g., autoimmune or neurodegenerative disease).

L'invention concerne un mélange d'interférons a (IFN-a) utilisé in vitro ou in vivo comme agent antimicrobien ou agent anticancéreux. Ce mélange peut être appliqué par administration à une muqueuse orale ou nasale et/ou buccale pour lutter contre les effets d'une infection par des bactéries ou des protozoaires, le cancer ou d'autres processus de maladies pathogènes (par exemple, une maladie autoimmune ou une maladie neurodégénérative).

Affiliated with

Also associated with

Rating

Genetic regulation of host defense mechanisms by mucosal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genetic regulation of host defense mechanisms by mucosal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic regulation of host defense mechanisms by mucosal... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1550155